Cardiac allograft vasculopathy: Advances in diagnosis

Cardiology in Review

Volumn 19, Issue 1, 2011, Pages 30-35

  Cai, Qiangjun ^a   Rangasetty, Umamahesh C ^a   Barbagelata, Alejandro ^a   Fujise, Kenichi ^a   Koerner, Michael M ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

angiography; Cardiac allograft vasculopathy; diagnosis; intravascular ultrasound; noninvasive testing

Indexed keywords

ANGIOGRAPHY; CARDIAC ALLOGRAFT VASCULOPATHY; COMPUTER ASSISTED TOMOGRAPHY; EARLY DIAGNOSIS; EXERCISE TEST; HUMAN; INTRAVASCULAR ULTRASOUND; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR STRESS TEST; POSITRON EMISSION TOMOGRAPHY; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRESS ECHOCARDIOGRAPHY;

GRAFT OCCLUSION, VASCULAR; HEART TRANSPLANTATION; HOST VS GRAFT REACTION; HUMANS; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 78650761552     PISSN: 10615377     EISSN: None     Source Type: Journal    
DOI: 10.1097/CRD.0b013e3181fbde2f     Document Type: Review

References (107)

1. Taylor DO, Stehlik J, Edwards LB, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-sixth official adult heart transplant report-2009. J Heart Lung Transplant. 2009;28:1007-1022.
2. Gao SZ, Alderman EL, Schroeder JS, et al. Accelerated coronary vascular disease in the heart transplant patient: coronary arteriographic findings. J Am Coll Cardiol. 1988;12:334-340.
3. Hoang K, Chen YD, Reaven G, et al. Diabetes and dyslipidemia. A new model for transplant coronary artery disease. Circulation. 1998;97:2160-2168.
4. Lee CM, Wu YW, Chou NK, et al. Intravascular ultrasound evidence of angiographically silent allograft vasculopathy inversely correlates with circulating level of hepatocyte growth factor. J Heart Lung Transplant.2006;25: 1456-1461.
5. Yamani MH, Tuzcu EM, Starling RC, et al. Computerized scoring of histopathology for predicting coronary vasculopathy, validated by intravascular ultrasound. J Heart Lung Transplant. 2002;21:850-859.
6. Starnes VA, Stinson EB, Oyer PE, et al. Cardiac transplantation in children and adolescents. Circulation. 1987;76:V43-V47.
7. Wong C, Ganz P, Miller L, et al. Role of vascular remodeling in the pathogenesis of early transplant coronary artery disease: a multicenter prospective intravascular ultrasound study. J Heart Lung Transplant. 2001;20:385-392.
8. Kobashigawa J, Wener L, Johnson J, et al. Longitudinal study of vascular remodeling in coronary arteries after heart transplantation. J Heart Lung Transplant. 2000;19:546-550.
9. Tsutsui H,Schoenhagen P,Ziada K,M,et al. Early constriction or expansion of the external elastic membrane area determines the late remodeling response and cumulative lumen loss in transplant vasculopathy: An intravascular ultrasound study with 4-year follow-up,J Heart Lung Transplant.2003;22519-525.
10. Jonas M, Fang JC, Wang JC, et al. In-stent restenosis and remote coronary lesion progression are coupled in cardiac transplant vasculopathy but not in native coronary artery disease. J Am Coll Cardiol. 2006;48:453-461.
11. Simpson L, Lee EK, Hott BJ, et al. Long-term results of angioplasty vs stenting in cardiac transplant recipients with allograft vasculopathy. J Heart Lung Transplant. 2005;24:1211-1217.
12. Rahmani M, Cruz RP, Granville DJ, et al. Allograft vasculopathy versus atherosclerosis. Circ Res. 2006;99:801-815.
13. Li H, Tanaka K, Anzai H, et al. Influence of pre-existing donor atherosclerosis on the development of cardiac allograft vasculopathy and outcomes in heart transplant recipients. J Am Coll Cardiol. 2006;47:2470-2476.
14. Botas J, Pinto FJ, Chenzbraun A, et al. Influence of pre-existing donor coronary artery disease on the progression of transplant vasculopathy. An intravascular ultrasound study. Circulation. 1995;92:1126-1132.
15. Aranda JM, Hill J. Cardiac transplant vasculopathy. Chest. 2000;118:1792-1800.
16. Dempsey SJ, D'Amico C, Weintraub WS, et al. Angiographic and clinical follow-up of percutaneous revascularization for transplant coronary artery disease. J Invasive Cardiol. 2000;12:311-315.
17. Halle AA III, DiSciascio G, Massin EK, et al. Coronary angioplasty, atherectomy and bypass surgery in cardiac transplant recipients. J Am Coll Cardiol. 1995;26:120-128.
18. Tanaka K, Li H, Curran PJ, et al. Usefulness and safety of percutaneous coronary interventions for cardiac transplant vasculopathy. Am J Cardiol. 2006;97:1192-1197.
19. Mehra MR. Contemporary concepts in prevention and treatment of cardiac allograft vasculopathy. Am J Transplant. 2006;6:1248-1256.
20. Kobashigawa JA, Katznelson S, Laks H, et al. Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med. 1995;333:621- 627.
21. Mehra MR, Uber PA, Vivekananthan K, et al. Comparative beneficial effects of simvastatin and pravastatin on cardiac allograft rejection and survival. J Am Coll Cardiol. 2002;40:1609-1614.
22. Johnson DE, Gao SZ, Schroeder JS, et al. The spectrum of coronary artery pathologic findings in human cardiac allografts. J Heart Transplant. 1989;8:349-359.
23. Pflugfelder PW, Boughner DR, Rudas L, et al. Enhanced detection of cardiac allograft disease with intracoronary ultrasonographic imaging. Am Heart J. 1993;125:1583-1591.
24. Costanzo MR, Naftel DC, Pritzker MR, et al. Heart transplant coronary artery disease detected by coronary angiography: a multiinstitutional study of preoperative donor and recipient risk factors. J Heart Lung Transplant.1998;17: 744-753.
25. Keogh AM, Valantine HA, Hunt SA, et al. Impact of proximal or midvessel discrete coronary artery stenoses on survival after heart transplantation. J Heart Lung Transplant. 1992;11:892-901.
26. Luyt CE, Drobinski G, Dorent R, et al. Prognosis of moderate coronary artery lesions in heart transplant patients. J Heart Lung Transplant. 2003;22:130-136.
27. Barbir M, Lazem F, Banner N, et al. The prognostic significance of non-invasive cardiac test in heart transplant recipients. Eur Heart J. 1997;18:692-696.
28. Nissen S. Coronary angiography and intravascular ultrasound. Am J Cardiol. 2001;87:15A-20A.
29. Rickenbacher PR, Pinto FJ, Chenzbraun A, et al. Incidence and severity of transplant coronary artery disease early and up to 15 years after transplantation as detected by intravascular ultrasound. J Am Coll Cardiol. 1995;25:171-177.
30. St. Goar FG, Pinto FJ, Aldermann EL, et al. Intracoronary ultrasound in cardiac transplant recipients: in vivo evidence of angiographically silent intimal thickening. Circulation. 1992;85:979-987.
31. Tuzcu EM, Hobbs RE, Rincon G, et al. Occult and frequent transmission of atherosclerotic coronary disease with cardiac transplantation: insights from intravascular ultrasound. Circulation. 1995;91:1706-1713.
32. Spes CH, Klauss V, Rieber J, et al. Functional and morphological findings in heart transplant recipients with a normal coronary angiogram: an analysis by dobutamine stress echocardiography, intracoronary Doppler and intravascular ultrasound. J Heart Lung Transplant. 1999;18:391-398.
33. Johnson DE, Aldermann EL, Schroeder JS, et al. Transplant coronary artery disease: histopathologic correlations with angiographic morphology. J Am Coll Cardiol. 1991;17:449-457.
34. Fang JC, Kinlay S, Wexberg P, et al. Use of the thrombolysis in myocardial infarction frame count for the quantitative assessment of transplant-associated arteriosclerosis. Am J Cardiol. 2000;86:890-892.
35. Wolford TL, Donohue TJ, Bach RG, et al. Heterogeneity of coronary flow reserve in the examination of multiple individual allograft coronary arteries. Circulation. 1999;99:626-632.
36. Mazur W, Bitar JN, Young JB, et al. Progressive deterioration of coronary flow reserve after heart transplantation. Am Heart J. 1998;136:504-509.
37. Korosoglou G, Riedle N, Erbacher M, et al. Quantitative myocardial blush grade for the detection of cardiac allograft vasculopathy. Am Heart J. 2010;159:643-651.
38. Rickenbacher PR, Pinto FJ, Lewis NP, et al. Prognostic importance of intimal thickness as measured by intracoronary ultrasound after cardiac transplantation. Circulation. 1995;92:3445-3452.
39. Tsutsui H, Ziada KM, Schoenhagen P, et al. Lumen loss in transplant coronary artery disease is a biphasic process involving early intimal thickening and late constrictive remodeling: results from a 5-year serial intravascular ultrasound study. Circulation. 2001;104:653-657.
40. Tuzcu EM, Kapadia SR, Sachar R, et al. Intravascular ultrasound evidence of angiographically silent progression in coronary atherosclerosis predicts long-term morbidity and mortality after cardiac transplantation. J Am Coll Cardiol. 2005;45:1538-1542.
41. Tuzcu EM, De Franco AC, Hobbs R, et al. Prevalence and distribution of transplant coronary artery disease: insights from intravascular ultrasound imaging. J Heart Lung Transplant. 1995;14:S202-S207
42. Mehra MR, Ventura HO, Smart FW, et al. An intravascular ultrasound study of the influence of angiotensin-converting enzyme inhibitors and calcium entry blockers on the development of cardiac allograft vasculopathy. Am J Cardiol. 1995;75:853-854.
43. Fang JC, Kinlay S, Beltrame J, et al. Effect of vitamins C and E on progression of transplant-associated arteriosclerosis: a randomised trial.Lancet. 2002;359:1108-1113.
44. Eisen HJ, Tuzcu EM, Dorent R, et al. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. N Engl J Med. 2003;349:847-858.
45. Tuzcu EM, Kapadia SR, Tutar E, et al. High prevalence of coronary atherosclerosis in asymptomatic teenagers and young adults: evidence from intravascular ultrasound. Circulation. 2001;103:2705-2710.
46. Yeung AC, Davis SF, Hauptman PJ, et al. Multicenter Intravascular Ultrasound Transplant Study Group. Incidence and progression of transplant coronary artery disease over 1 year: results of a multicenter trial with use of intravascular ultrasound. J Heart Lung Transplant. 1995;14:S215-S220.
47. Lee CM, Wu YW, Jui HY, et al. Intravascular ultrasound correlates with coronary flow reserve and predicts the survival in angiographically normal cardiac transplant recipients. Cardiology. 2008;109:93-98.
48. Li H, Tanaka K, Oeser B, et al. Vascular remodelling after cardiac transplantation:a 3-year serial intravascular ultrasound study. Eur Heart J.2006;27:1671-1677.
49. Lim TT, Liang DH, Botas J, et al. Role of compensatory enlargement and shrinkage in transplant coronary artery disease. Serial intravascular ultrasound study. Circulation. 1997;95:855-859.
50. Pethig K, Heublein B, Meliss RR, et al. Volumetric remodeling of the proximal left coronary artery: early versus late after heart transplantation.J Am Coll Cardiol. 1999;34:197-203.
51. Mehra MR, Ventura HO, Stapleton DD, et al. Presence of severe intimal thickening by intravascular ultrasonography predicts cardiac events in cardiac allograft vasculopathy. J Heart Lung Transplant. 1995;14:632-639.
52. Kobashigawa JA, Tobis JM, Starling RC, et al. Multicenter intravascular ultrasound validation study among heart transplant recipients: outcomes after five years. J Am Coll Cardiol. 2005;45:1532-1537.
53. Zakliczynski M, Swierad M, Zakliczynska H, et al. Usefulness of Stanford scale of intimal hyperplasia assessed by intravascular ultrasound to predict time of onset and severity of cardiac allograft vasculopathy. Transplant Proc. 2005;37:1343-1345.
54. Palmer ND, Northridge D, Lessells A, et al. In vitro analysis of coronary atheromatous lesions by intravascular ultrasound; reproducibility and histological correlation of lesion morphology. Eur Heart J. 1999;20:1701-1706.
55. Peters RJ, Kok WE, Havenith MG, et al. Histopathologic validation of intracoronary ultrasound imaging. J Am Soc Echocardiogr. 1994;7:230-241.
56. Hernandez JM, de Prada JA, Burgos V, et al. Virtual histology intravascular ultrasound assessment of cardiac allograft vasculopathy from 1 to 20 years after heart transplantation. J Heart Lung Transplant. 2009;28:156-162.
57. König A, Kilian E, Sohn HY, et al. Assessment and characterization of time-related differences in plaque composition by intravascular ultrasoundderived radiofrequency analysis in heart transplant recipients. J Heart Lung Transplant. 2008;27:302-309.
58. Raichlin E, Bae JH, Kushwaha SS, et al. Inflammatory burden of cardiac allograft coronary atherosclerotic plaque is associated with early recurrent cellular rejection and predicts a higher risk of vasculopathy progression. J Am Coll Cardiol. 2009;53:1279-1286.
59. Pinto FJ, St. Goar FG, Gao SZ, et al. Immediate and one-year safety of intracoronary ultrasonic imaging. Evaluation with serial quantitative angiography.Circulation. 1993;88:1709-1714.
60. Hausmann D, Erbel R, Alibelli-Chemarin MJ, et al. The safety of intracoronary ultrasound. A multicenter survey of 2207 examinations. Circulation.1995;91:623-630.
61. Alfonso F, Flores A, Escaned J, et al. Pressure wire kinking, entanglement,and entrapment during intravascular ultrasound studies: a potentially dangerous complication. Cathet Cardiovasc Intervent. 2000;50:221-225.
62. Tobis JM, Mallery J, Mahon D, et al. Intravascular ultrasound imaging of human coronary arteries in vivo. Analysis of tissue characterizations with comparison to in vitro histological specimens. Circulation. 1991;83:913-926.
63. Ramasubbu K, Schoenhagen P, Balghith MA, et al. Repeated intravascular ultrasound imaging in cardiac transplant recipients does not accelerate transplant coronary artery disease. J Am Coll Cardiol. 2003;41:1739-1943.
64. Son R, Tobis JM, Yeatman LA, et al. Does use of intravascular ultrasound accelerate arteriopathy in heart transplant recipients? Am Heart J. 1999;138:358-363.
65. Clausell N, Butany J, Molossi S, et al. Abnormalities in intramyocardial arteries detected in cardiac transplant biopsy specimens and lack of correlation with abnormal intracoronary ultrasound or endothelial dysfunction in large epicardial coronary arteries. J Am Coll Cardiol. 1995;26:110-119.
66. Kapadia SR, Ziada KM, L'Allier PL, et al. Intravascular ultrasound imaging after cardiac transplantation: advantage of multivessel imaging. J Heart Lung Transplant. 2000;19:167-172.
67. D'Errico V, Potena L, Fiore D, et al. Reproducibility of IVUS measurements in heart transplant recipients: increased quality of data by using dedicated software for image analysis. Comput Cardiol. 2008;35:537-540.
68. Smart FW, Ballantyne CM, Cocanougher B, et al. Insensitivity of noninvasive tests to detect coronary artery vasculopathy after heart transplant. Am J Cardiol. 1991;67:243-247.
69. Ehrman JK, Keteyian SJ, Levine AB, et al. Exercise stress tests after cardiac transplantation. Am J Cardiol. 1993;71:1372-1373.
70. Ciliberto GR, Massa D, Mangiavacchi M, et al. High-dose dipyridamole echocardiography test in coronary artery disease after heart transplantation.Eur Heart J. 1993;14:48-52.
71. Derumeaux G, Redonnet M, Mouton-Schleifer D, et al. Dobutamine stress echocardiography in orthotopic heart transplant recipients. J Am Coll Cardiol. 1995;25:1665-1672.
72. Spes CH, Mudra H, Schnaack SD, et al. Dobutamine stress echocardiography for noninvasive diagnosis of cardiac allograft vasculopathy: a comparison with angiography and intravascular ultrasound. Am J Cardiol. 1996;78:168-174.
73. Spes CH, Klauss V, Mudra H, et al. Diagnostic and prognostic value of serial dobutamine stress echo-cardiography for noninvasive assessment of cardiac allograft vasculopathy: a comparison with coronary angiography and intravascular ultrasound. Circulation. 1999;100:509-515.
74. Akosah KO, Mohanty PK, Funai JT, et al. Noninvasive detection of transplant coronary artery disease by dobutamine stress echocardiography. J Heart Lung Transplant. 1994;13:1024-1038.
75. Akosah KO, McDaniel S, Hanrahan JS, et al. Dobutamine stress echocardiography early after heart transplantation predicts development of allograft coronary artery disease and outcome. J Am Coll Cardiol. 1998;31:1607-1614.
76. Jackson PA, Akosah KO, Kirchberg DJ, et al. Relationship between dobutamine-induced regional wall motion abnormalities and coronary flow reserve in heart transplant patients without angiographic coronary arterydisease. J Heart Lung Transplant. 2002;21:1080-1089.
77. Rodrigues AC, Bacal F, Medeiros CC, et al. Noninvasive detection of coronary allograft vasculopathy by myocardial contrast echocardiography.J Am Soc Echocardiogr. 2005;18:116-121.
78. Tona F, Caforio AL, Montisci R, et al. Coronary flow velocity pattern and coronary flow reserve by contrast-enhanced transthoracic echocardiography predict long-term outcome in heart transplantation. Circulation. 2006;114:I49-I55.
79. Hacker M, Hoyer HX, Uebleis C, et al. Quantitative assessment of cardiac allograft vasculopathy by real-time myocardial contrast echocardiography: acomparison with conventional echocardiographic analyses and [Tc99m]-sestamibi SPECT. Eur J Echocardiogr. 2008;9:494-500.
80. Tona F, Caforio AL, Montisci R, et al. Coronary flow reserve by contrastenhanced echocardiography: a new noninvasive diagnostic tool for cardiac allograft vasculopathy. Am J Transplant. 2006;6:998-1003.
81. Carlsen J, Toft JC, Mortensen SA, et al. Myocardial perfusion scintigraphy as a screening method for significant coronary artery stenosis in cardiac transplant recipients. J Heart Lung Transplant. 2000;19:873-878.
82. Wu YW, Yen RF, Lee CM, et al. Diagnostic and prognostic value of dobutamine thallium-201 single-photon emission computed tomography after heart transplantation. J Heart Lung Transplant. 2005;24:544-550.
83. Ciliberto GR, Mangiavacchi M, Banfi F, et al. Coronary artery disease after heart transplantation: noninvasive evaluation with exercise thallium scintigraphy. Eur Heart J. 1993;14:226-229.
84. Rodney RA, Johnson LL, Blood DK, et al. Myocardial perfusion scintigraphy in heart transplant recipients with and without allograft atherosclerosis: a comparison of thallium-201 and technetium 99m sestamibi. J Heart Lung Transplant. 1994;13:173-180.
85. Ambrosi P, Habib G, Kreitman B, et al. Thallium perfusion and myocardial hypertrophy in transplanted heart recipients with normal or near-normal coronary arteriograms. Eur Heart J. 1994;15:1119-1123.
86. Howarth DM, Forstrom LA, Samudrala V, et al. Evaluation of 201Tl SPECT myocardial perfusion imaging in the detection of coronary artery disease after orthotopic heart transplantation. Nucl Med Commun. 1996;17:105-113.
87. Ciliberto GR, Ruffini L, Mangiavacchi M, et al. Resting echocardiography and quantitative dipyridamole technetium-99m sestamibi tomography in the identification of cardiac allograft vasculopathy and the prediction of longterm prognosis after heart transplantation. Eur Heart J. 2001;22:964-971.
88. Elhendy A, Sozzi FB, van Domburg RT, et al. Accuracy of dobutamine tetrofosmin myocardial perfusion imaging for the noninvasive diagnosis of transplant coronary artery stenosis. J Heart Lung Transplant. 2000;19:360-366
89. Hacker M, Tausig A, Romuller B, et al. Dobutamine myocardial scintigraphy for the prediction of cardiac events after heart transplantation. Nucl Med Commun. 2005;26:607-612.
90. Elhendy A, van Domburg RT, Vantrimpont P, et al. Prediction of mortality in heart transplant recipients by stress technetium-99m tetrofosmin myocardial perfusion imaging. Am J Cardiol. 2002;89:964-968.
91. Romeo G, Houyel L, Angel CY, et al. Coronary stenosis detection by 16-slice computed tomography in heart transplant patients: comparison with conventional angiography and impact on clinical management. J Am Coll Cardiol. 2005;45:1826-1831.
92. Sigurdsson G, Carrascosa P, Yamani MH, et al. Detection of transplant coronary artery disease using multidetector computed tomography with adaptative multisegment reconstruction. J Am Coll Cardiol. 2006;48:772-778.
93. Iyengar S, Feldman DS, Cooke GE, et al. Detection of coronary artery disease in orthotopic heart transplant recipients with 64-detector row computed tomography angiography. J Heart Lung Transplant. 2006;25:1363-1366.
94. Bogot NR, Durst R, Shaham D, et al. Cardiac CT of the transplanted heart: indications, technique, appearance, and complications. Radiographics. 2007;27:1297-1309.
95. Nunoda S, Machida H, Sekikawa A, et al. Evaluation of cardiac allograft vasculopathy by multidetector computed tomography and whole-heart magnetic resonance coronary angiography. Circ J. 2010;74:946-953.
96. Schepis T, Achenbach S, Weyand M, et al. Comparison of dual source computed tomography versus intravascular ultrasound for evaluation of coronary arteries at least one year after cardiac transplantation. Am J Cardiol. 2009;104:1351-1356.
97. Knollmann FD, Bocksch W, Spiegelsberger S, et al. Electron-beam computed tomography in the assessment of coronary artery disease after heart transplantation. Circulation. 2000;101:2078-2082.
98. Ratliff NB III, Jorgensen CR, Gobel FL, et al. Lack of usefulness of electron beam computed tomography for detecting coronary allograft vasculopathy. Am J Cardiol. 2004;94:202-206.
99. Caus T, Kober F, Marin P, et al. Non-invasive diagnostic of cardiac allograft vasculopathy by 31P magnetic resonance chemical shift imaging. Eur J Cardiothorac Surg. 2006;29:45-49.
100. Muehling OM, Wilke NM, Panse P, et al. Reduced myocardial perfusion reserve and transmural perfusion gradient in heart transplant arteriopathy assessed by magnetic resonance imaging. J Am Coll Cardiol. 2003;42: 1054-1060.
101. Bengel FM, Higuschi T, Jawadi MS, et al. Cardiac positron emission tomography. J Am Coll Cardiol. 2009;54:1-15.
102. Uren NG, Melin JA, De Bruyne B, et al. Relation between myocardial blood flow and the severity of coronary stenosis. N Engl J Med. 1994;330:1782-1788.
103. Allen-Auerbach M, Schroeder H, Johnson J, et al. Relation between coronary function by positron emission tomography and temporal changes in morphology by intravascular ultrasound (IVUS) in transplant recipients. J Heart Lung Transplant. 1999;18:211-219.
104. Preumont N, Berkenboom G, Vachiery J, et al. Early alterations of myocardial blood flow reserve in heart transplant recipients with angiographically normal coronary arteries. J Heart Lung Transplant. 2000;19:538-545.
105. Wu YW, Chen YH, Wang SS, et al. PET assessment of myocardial perfusion reserve inversely correlates with intravascular ultrasound findings in angiographically normal cardiac transplant recipients. J Nucl Med. 2010; 51:906-912.
106. Costanzo MR, Dipchand A, Starling R, et al. The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. J Heart Lung Transplant. 2010;29:914-956.
107. Arora S, Gunther A, Wennerblom B, et al. Systemic markers of inflammation are associated with cardiac allograft vasculopathy and an increased intimal inflammatory component. Am J Transplant. 2010;10:1428-1436.